Faron Pharmaceuticals Oy (LON:FARN – Get Rating) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 191.41 ($2.31) and traded as low as GBX 173 ($2.09). Faron Pharmaceuticals Oy shares last traded at GBX 185 ($2.24), with a volume of 44,154 shares trading hands.
Faron Pharmaceuticals Oy Price Performance
The firm has a fifty day moving average price of GBX 191.41 and a two-hundred day moving average price of GBX 213.68. The stock has a market capitalization of £102.24 million and a P/E ratio of -5.15. The company has a debt-to-equity ratio of 121.51, a quick ratio of 1.09 and a current ratio of 1.70.
Faron Pharmaceuticals Oy Company Profile
(Get Rating)
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Its lead product candidates are Traumakine, an intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies.
Recommended Stories
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- No One Told These 3 Stocks It's a Down Week
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.